Early Results of Transcutaneous Injection Laryngoplasty with Micronized Acellular Dermis Versus Type-I Thyroplasty for Glottic Incompetence Dysphonia Due to Unilateral Vocal Fold Paralysis

Journal of Voice

Volumn 17, Issue 4, 2003, Pages 589-595

  Lundy, Donna S ^a,b   Casiano, Roy R ^a,b   McClinton, Mark E ^a,b   Xue, Jun W ^a,b  

^a Department of Otolaryngology ^*

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Acellular collagen; Medialization thyroplasty

Indexed keywords

COLLAGEN; ELASTIN;

ACOUSTICS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; DYSPHONIA; FEMALE; GLOTTIS; HUMAN; IATROGENIC DISEASE; IDIOPATHIC DISEASE; INTERMETHOD COMPARISON; LARYNGOPLASTY; LARYNGOSCOPY; LARYNX CARTILAGE; MALE; MEDIALIZATION THYROPLASTY; PERCEPTION; RATING SCALE; SPEECH DISORDER; STROBOSCOPY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VOCAL CORD PARALYSIS; VOICE;

EID: 0346250897     PISSN: 08921997     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0892-1997(03)00081-X     Document Type: Article

References (45)

1. Isshiki N, Morita H, Okamura H, et al. Thyroplasty as a new phonosurgical technique. Acta Otolaryngol (Stockh). 1974;78:451-457.
2. Sasaki CT, Leder SB, Petcu L, et al. Longitudinal voice quality changes following Isshiki thyroplasty type I: the Yale experience. Laryngoscope. 1990;100:849-852.
3. Lu FL, Casiano RR, Lundy DS, Xue JW. Longitudinal evaluation of vocal function following thyroplasty type I in the treatment of unilateral vocal paralysis. Laryngoscope. 1996;106:573-577.
4. Omori K, Slavit DH, Kacker A, et al. Effects of thyroplasty type I on vocal fold vibration. Laryngoscope. 2000;110:1086-1091.
5. McCulloch TM, Hoffman HT, Andrews BT, et al. Arytenoid adduction combined with Gore-Tex medialization thyroplasty. Laryngoscope. 2000;110:1306-1311.
6. Koufman JA. Laryngoplasty for vocal cord medialization: an alternative to Teflon. Laryngoscope. 1986;96:726-731.
7. Gardner GM, Parnes SM. Status of the mucosal wave post vocal cord injection versus thyroplasty. J Voice. 1991;5:64-73.
8. Lundy DS, Casiano RR, Xue JW, et al. Thyroplasty type I: short-versus long-term results. Otolaryngol Head Neck Surg. 2000;122:533-536.
9. Dedo HH, Urrea RD, Lawson L. Intracordal injection of Teflon in the treatment of 135 patients with dysphonia. Ann Otol Rhinol Laryngol. 1973;82:661-667.
10. Strasnick B, Berke GS, Ward PH. Transcutaneous Teflon injection for unilateral vocal cord paralysis: an update. Laryngoscope. 1991;101:785-787.
11. McCaffrey TV. Transcutaneous Teflon injection for vocal cord paralysis. Otolaryngol Head Neck Surg. 1993;109:54-59.
12. Ford CN, Bless DM. Clinical experience with injectable collagen for vocal fold augmentation. Laryngoscope. 1986;96:863-869.
13. Ford CN, Staskowski PA, Bless DM. Autologous collagen vocal fold injection: a preliminary clinical study. Laryngoscope. 1995;105:944-948.
14. Remacle M, Lawson G, Keghian J, et al. Use of injectable autologous collagen for correcting glottic gaps: initial results. J Voice. 1999;13:280-288.
15. Mikaelian DO, Lowry LD, Sataloff RT. Lipoinjection for unilateral vocal cord paralysis. Laryngoscope. 1991;101:465-468.
16. Shindo ML, Zaretsky LS, Rice DH. Autologous fat injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol. 1996;105:602-606.
17. Rihkanen H. Injection of autologous fascia in augmentation of vocal fold paralysis. Laryngoscope. 1998;108:51-54.
18. Duke SG, Salmon J, Blalock PD, et al. Fascia augmentation of the vocal fold: graft yield in the canine and preliminary clinical experience. Laryngoscope. 2001;111:759-764.
19. Schramm VL, May M, Lavorato AS. Gelfoam paste injection for vocal cord paralysis: temporary rehabilitation of glottic incompetence. Laryngoscope. 1978;88:1268-1273.
20. Lewy RB. Teflon injection of the vocal cord: complications, errors, and precautions. Ann Otol Rhinol Laryngol. 1983;92:473-474.
21. Nakayama M, Ford C, Bless D. Teflon vocal fold augmentation: failures and management in 28 cases. Otolaryngol Head Neck Surg. 1993;109:493-498.
22. Ossoff RH, Koriwchak MJ, Netterville JL, et al. Difficulties in endoscopic removal of Teflon granulomas of the vocal fold. Ann Otol Rhinol Laryngol. 1993;102:405-412.
23. Charrier B, Bejot M, Schnitzler L, et al. Reactions to a bovine collagen implant. J Am Acad Dermatol. 1989;21:1203-1208.
24. Takayama E, Ikeda M, Tsuru S, et al. Is injectable collagen truly safe? J Laryngol Otol. 1992;106:704-708.
25. Courey MS. Homologous collagen substances for vocal fold augmentation. Laryngoscope. 2001;111:747-758.
26. Mikus JL, Koufman JA, Kilpatrick SE. Fate of liposuctioned and purified autologous fat injections in the canine vocal fold. Laryngoscope. 1995;105:17-22.
27. Saccogna PW, Werning JW, Setrakian S, et al. Lipoinjection in the paralyzed feline vocal fold: study of graft survival. Otolaryngol Head Neck Surg. 1997;117:465-470.
28. Shaw GY, Szewczyk MA, Searle J, et al. Autologous fat injection into the focal folds: technical considerations and long-term follow-up. Laryngoscope. 1997;107:177-186.
29. Anderson TD, Mirza N. Immediate percutaneous medialization for acute vocal fold immobility with aspiration. Laryngoscope. 2001;111:1318-1321.
30. Netterville JL. Rehabilitation of the unilaterally paralyzed larynx. Otolaryngol Head Neck Surg. 1997;5:122-128.
31. Fagian S. Facial soft tissue augmentation with injectable autologous and allogeneic human tissue collagen matrix (Autologen and Dermalogen). Plast Reconstr Surg. 2000;105:362-373.
32. Pearl A, Passalaqua P, Ramos-Pizarro CA. Glottic insufficiency treated by Cymetra injection laryngoplasty. [Abstract] Otolaryngol Head Neck Surg. 2001;125:150.
33. Cheng JT, Perkins SW, Hamilton MM. Collagen and injectable fillers. Otolaryngol Clin North Am. 2002;35:73-85.
34. Wainwright DJ. Use of acellular dermal graft matrix (Alloderm) in the management of full thickness burns. Burns. 1995;21:243-248.
35. Jones FR, Schwartz BM, Silverstein P. Use of a non-immunogenic acellular dermal allograft for soft tissue augmentation: a preliminary report. Aesthetic Surg J. 1996;16:196-201.
36. Castor SA, To WC, Papay FA. Lip augmentation with Alloderm acellular dermal graft and fat autograft: a comparison with autologous fat injection alone. Aesth Plast Surg. 1999;23:218-223.
37. Sclafani AP, Romo T, Jacono AA, et al. Evaluation of acellular dermal graft in sheet (Alloderm) and injectable (micronized Alloderm) forms for soft tissue augmentation. Arch Facial Plast Surg. 2000;2:130-136.
38. Spector BC, Netterville JL, Billante C, et al. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg. 2001;125:176-182.
39. Omori K, Kacker A, Slavit DH, et al. Quantitative video-stroboscopic measurement of glottal gap and vocal function: an analysis of thyroplasty type, I. Ann Otol Rhinol Laryngol. 1996;105:280-285.
40. McLean-Muse A, Montgomery WW, Hillman RE, et al. Montgomery thyroplasty implant for vocal fold immobility: phonatory outcomes. Ann Otol Rhinol Laryngol. 2000;109:393-400.
41. Adams SG, Irish JC, Durkin LC, et al. Evaluation of vocal function in unilateral vocal fold paralysis following thyroplastic surgery. J Otolaryngol. 1996;25:165-170.
42. Leder SB, Sasaki CT. Long-term changes in vocal quality following Isshiki thyroplasty type I. Laryngoscope. 1994;104:275-277.
43. Passalaqua P, Pearl A, Woo P. Direct transcutaneous translaryngeal injection laryngoplasty with Alloderm. Paper Presentation. Philadelphia, PA: Presented at 30th annual symposium: Care of the professional voice; 2001.
44. Jacobson BH, Johnson A, Grywalski C, et al. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol. 1997;6:66-70.
45. Thompson DM, Maragos NE, Edwards BW. The study of vocal fold vibratory patterns in patients with unilateral vocal fold paralysis before and after type I thyroplasty with or without arytenoid adduction. Laryngoscope. 1995;105:481-486.